Financials
2023 Full Year Results and Annual Report | Jun. 07, 2024 |
Half-year Report | Sep. 25, 2023 |
Annual Report for the Year Ended 31 December 2022 | May. 23, 2023 |
Full Year Results | May. 10, 2023 |
Proxies
Notice of AGM and Directorate Change | Jun. 06, 2024 |
Result of AGM | May. 25, 2023 |
Notice of AGM | May. 03, 2023 |
Ownership Update
Ondine President increases shareholding | Feb. 06, 2025 |
Ondine CEO increases shareholding | Feb. 04, 2025 |
Ondine CEO increases ownership | Feb. 03, 2025 |
CEO Increases Stake in Ondine | Jan. 31, 2025 |
Replacement: Director Increases Stake in Ondine | Jan. 31, 2025 |
Director Increases Stake in Ondine | Jan. 31, 2025 |
Notification of Major Holdings | Jan. 30, 2025 |
Announcements
Appointment of Nominated and Financial Adviser | Feb. 03, 2025 |
HCA to invest US$4 million in Ondine | Jan. 27, 2025 |
Ondine recruits first patient for US Phase 3 trial | Dec. 30, 2024 |
Final Result of Fundraise & TVR | Nov. 15, 2024 |
Updated Result of Fundraise | Nov. 14, 2024 |
Update on Private Placement and Placing | Nov. 11, 2024 |
Result of Fundraise | Nov. 01, 2024 |